NCT02411786 2021-02-04
A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF
University of Wisconsin, Madison
Phase 1 Completed
Clinical Trials
3 trialsNCT04072900 2020-04-28
A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma
Xiangya Hospital of Central South University
Phase 1 Unknown
NCT00582140 2019-11-19
Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer
University of Wisconsin, Madison
Phase 1 Completed